
Gitune 150mg Tablet SR
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Itopride (150mg)
Overview Gitune 150mg Tablet SR
GastroGard 150mg Extended-Release Tablets are a prescription medication indicated for managing nausea and vomiting, and mitigating postprandial satiety. It also addresses stomach upset and heartburn stemming from diminished gastrointestinal motility. GastroGard 150mg Extended-Release Tablets are administered before meals, with dosage and treatment duration determined by your physician. Your prescribed regimen will be tailored to your individual needs and response. Continue taking this medication as directed by your doctor. Inform your doctor of all other medications you are currently using, as interactions are possible. The most frequently reported side effects include loose stools and abdominal discomfort, typically transient and resolving spontaneously. Consult your physician if side effects are concerning. Drowsiness and lightheadedness may occur; refrain from driving or activities demanding concentration until you assess the medication's impact on you. Alcohol consumption should be avoided due to potential additive sedative effects. Given the possibility of diarrhea, adequate hydration is recommended to minimize dehydration risk. Prior to commencing treatment, disclose any liver or kidney conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before using this medication.
Primary Ingredients of Gitune 150mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Gitune 150mg Tablet SR
Managing Acid Reflux and Queasiness
Major Benefits of Gitune 150mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Gitune 150mg Tablet SR whole; do not chew, crush, or break it. Administer on an empty stomach.
Common Side effects of Gitune 150mg Tablet SR:
- Diarrhea
How to use Gitune 150mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gitune 150mg Tablet SR whole; do not crush, chew, or fracture it. Administer on an empty stomach.
How Gitune 150mg Tablet SR works:
Gitune 150mg Extended-Release Tablets exert a prokinetic effect. This medication targets the brain's emetic center, suppressing the urge to vomit. Simultaneously, it enhances gastrointestinal motility in the upper digestive system, facilitating smoother passage of food through the stomach.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Gitune 150mg Tablet SR is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Gitune 150mg sustained-release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Gitune 150mg tablets are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Gitune 150mg Tablet SR is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Gitune 150mg sustained-release tablets in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Gitune 150mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gitune 150mg Tablet SR :
Should you forget a dose of Gitune 150mg Tablet SR, take it immediately if remembered. However, near the time for your next scheduled dose, omit the missed dose and resume your normal dosage routine. Avoid taking a double dose.
Facts to Know About Gitune 150mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Benzamide Analog |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Active Class | Prokinetic agent with dopamine D2 receptor antagonism |
